Posted on February 10, 2020
Following the 4-year transition period, the medicine labelling Therapeutic Goods Orders (TGOs), TGO 91 for prescription medicines and TGO 92 for non-prescription medicines, will become mandatory on 1 September 2020.
Medicines that are released for supply on or after 1 September 2020 must comply with either TGO 91 or TGO 92, whichever is relevant.
Sponsors should check that their medicine labels comply with the relevant TGO and if not, applications to update the labels should be submitted now to ensure they are approved in time for use in stock released after 1 September 2020.
For assistance in undertaking a review or updating and developing medicine labels that comply with TGO 91 or TGO 92, please contact our expert Regulatory Services team on +61 3 9251 0777